tiprankstipranks
Advertisement
Advertisement
Galmed and Tissue Dynamics’ two-drug combination targets cardiac fibrosis
PremiumThe FlyGalmed and Tissue Dynamics’ two-drug combination targets cardiac fibrosis
1M ago
Galmed and Tissue Dynamics’ two-drug combination targets cardiac fibrosis
Premium
The Fly
Galmed and Tissue Dynamics’ two-drug combination targets cardiac fibrosis
1M ago
Galmed Reports Fivefold Bioavailability Boost with New Aramchol Meglumine Oral Formulation
Premium
Company Announcements
Galmed Reports Fivefold Bioavailability Boost with New Aramchol Meglumine Oral Formulation
2M ago
Galmed announces research agreement with Ramot at Tel Aviv University
PremiumThe FlyGalmed announces research agreement with Ramot at Tel Aviv University
3M ago
Morning News Wrap-Up 4/9/26: Today’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up 4/9/26: Today’s Biggest Stock Market Stories!
3M ago
Galmed Unveils Brain-Penetrant Aramchol Formulation, Expanding Flagship Drug Into CNS Diseases
Premium
Company Announcements
Galmed Unveils Brain-Penetrant Aramchol Formulation, Expanding Flagship Drug Into CNS Diseases
3M ago
Galmed Pharmaceuticals Sets March 4 Vote on Reverse Stock Split to Address Nasdaq Listing Deficiency
PremiumCompany AnnouncementsGalmed Pharmaceuticals Sets March 4 Vote on Reverse Stock Split to Address Nasdaq Listing Deficiency
5M ago
Galmed Pharmaceuticals Receives Nasdaq Minimum Bid Price Deficiency Notice
Premium
Company Announcements
Galmed Pharmaceuticals Receives Nasdaq Minimum Bid Price Deficiency Notice
5M ago
Galmed Pharmaceuticals’ Aramchol Study: Key Updates and Market Implications
Premium
Company Announcements
Galmed Pharmaceuticals’ Aramchol Study: Key Updates and Market Implications
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100